Harbor Custom Development (NASDAQ:HCDI) reported quarterly losses of $(0.46) per share. This is a 866.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $10.30
75% survival in patients with severe respiratory distress treated with agenT-797agenT-797 improved lung function, significantly reduced inflammation and secondary infectionsMiNK to advance agenT-797 in ARDS through